Navigation Links
Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
Date:6/16/2008

SAN DIEGO, June 16 /PRNewswire/ -- Victory Pharma, Inc., a specialty pharmaceutical company focused on pain and related areas of medicine, today announced the recent initiation of the first of two clinical studies for MGX006 antiemetic pivotal clinical program.

"Data from the Phase 2 studies confirming pivotal formulation selection and end-of-phase 2 discussions with the FDA regarding the registration study designs provides confidence that MGX006 will move rapidly through pivotal development," explained Dr. Shawn Scranton, Vice President of Scientific Operations. "Victory is pleased with the results to date and is confident that MGX006 will provide an important therapeutic alternative for patients suffering from emesis of various etiologies," continued Dr. Scranton.

"MGX006 represents a key milestone for Victory," stated Matthew Heck, President and CEO. "This novel approach to antiemetic therapy is the company's first internally developed pipeline product, demonstrating our commitment to developing solutions for unmet medical needs. We look forward to marketing MGX006 in the U.S. with our specialty sales force."

About MGX006

MGX006 utilizes a proprietary formulation applied to a previously approved antiemetic agent. The formulation was created utilizing patented technology through a partnership and has properties that make MGX006 ideally suited for the treatment of nausea and vomiting.

About Victory Pharma, Inc.

Victory Pharma, Inc. is a private San Diego based specialty pharmaceutical company focused on acquiring, marketing and developing proprietary pain and related products. Victory markets its existing pain products through its field sales force headquartered in Cary, NC, and is currently developing several products in pain and pain complementary markets. Further information regarding Victory is available at http://www.VictoryPharma.com.


'/>"/>
SOURCE Victory Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014  Researchers from the North American Menopause ... elevates calcium levels too high, 1 putting women ... Women close to menopause are commonly told ... prevent diseases such as osteoporosis, to which they are ... determine how much calcium they typically get through their ...
(Date:7/23/2014)... 23, 2014  Mevesi Inc. would like to ... integration provides pharmacies with the ability to send ... patients. Mevesi,s solutions provide an ... to define target marketing campaigns. This coupled with ... within the Digital Marketing, Population Management, and Pharmacy ...
(Date:7/23/2014)... 2014 Global healthcare company GSK ... currency headwinds, increased price competition and supply disruptions to ... Witty points out that the company is very much ... to be confident about long-term prospects as well as ... CFO Simon Dingemans adds that the ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 2Mevesi Enhances Solutions with Variable Print Media Capabilities! 2
... , , Trial taking place ... Ky., July 24 Michael (Mike) Jones has become the world,s first ... infusion on July 17 marks the world,s first phase-one FDA-approved clinical trial ... is being conducted by a team of University of Louisville physicians at ...
... , WISCONSIN RAPIDS, Wis., July 23 ... Riverview became the first medical facility in the world to ... within Riverview Hospital, Wisconsin Rapids, the UW Cancer Center Riverview ... FDA-cleared Axxent(R) Electronic Brachytherapy System from Xoft, Inc. Electronic Brachytherapy, ...
Cached Medicine Technology:World's First Cardiac Adult Stem Cell Patient Receives Infusion 2First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center 2First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center 3
(Date:7/23/2014)... Celebrating a decade of philanthropy in ... the awarding of $1,070,000 in grants to 20 New ... of the Foundation’s 1,000th grant. , “The Horizon Foundation ... of supporting community-based organizations that are working to improve ... the Garden State,” said Robert A. Marino, Horizon Blue ...
(Date:7/23/2014)... study supports a growing body of research suggesting ... hormones in treating postmenopausal breast cancer, with fewer ... with standard anti-hormone therapies. The study will be ... journal Reproductive Biology and Endocrinology . , ... in women in the United States. Approximately 70% ...
(Date:7/23/2014)... Global Cardio Care, Inc., a management ... (EECP), is celebrating the 100th birthday of Albert ... health center. , Weber has been plagued with ... EECP therapy since 1999, he no longer suffers from ... Global Cardio Care, introduced the Sara Soulati Health ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The voice on the ... call that brought the news he was infected with the human ... a little bit and next thing you know I was on ... , Yet the message was hopeful when the recording ended less ... of you . . . because it is just God ...
(Date:7/23/2014)... -- For patients infected with both HIV and hepatitis ... viruses, a small study suggests. Researchers said doctors ... people with the two diseases. "The findings ... important role in the management of individuals with [hepatitis ... Sherman, a professor of medicine at the University of ...
Breaking Medicine News(10 mins):Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2
... finds children with sickle cell disease are more likely to ... if they live in households where people smoke.// ,Study ... harm the health of nonsmokers. It is found that exposure ... to a vast array of problems. ,In sickle ...
... show obese men with prostate cancer are at a higher ... recurrence than men of normal weight.// ,The first ... San Diego sampled nearly 3,200 prostate cancer patients. In this ... defined as having a body mass index higher than 30. ...
... valacyclovir may significantly reduce the spread of the genital ... each case, one partner was diagnosed with //type 2 ... Type 2 herpes causes a chronic genital viral infection ... herpes were given either 500 milligrams of valacyclovir once ...
... New research proves drug-coated stents effectively combat death, heart ... a closer look at the effects of drug-coated stents ... 500 patients with previously untreated blocked arteries who were ... comparable blockages were treated with bare metal stents. ...
... million service men and women before and after the Air ... rate of suicide seen among Air Force personnel. // ... for black and white males ages 24 to 35, between ... are to provide support for soldiers facing mental health or ...
... simplex virus is a common eye disease affecting people worldwide. ... cases are identified // annually. The disease is caused by ... get the infection will have repeat infections. The recurrence rate ... five years, and 67 percent within seven years. ...
Cached Medicine News:Health News:Prostate Cancer in Obese Men 2
...
Small diameter high tech flexoscopes...
... cervical plate system features an advanced design ... needs. Trinica system gives surgeons the flexibility ... unique anatomy. Flexibility is built-in to every ... and the innovative Secure-Twist anti-migration system to ...
... intended for supportive stabilization of the ... The device utilizes bi-cortical fixation for ... enhanced through dynamic screw holes and ... level interbody fusion. Anterior cervical corpectomy. ...
Medicine Products: